Syntec Optics Holdings, Inc.
OPTXSyntec Optics Holdings, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Syntec Optics Holdings, Inc. trades at $7.9, between stages. That is +22.0% against its own 200-day average. It sits at 56% of a 52-week range of $1 to $13. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week.
Today the stock is between stages. At $7.9 it trades +22.0% versus its 200-day average and sits at 56% of its 52-week range ($1–$13).
Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved +491% while the S&P 500 moved +24% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
P/E does not price Syntec Optics Holdings, Inc. — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. A P/E returns here the first period the bottom line turns positive.
With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Syntec Optics Holdings, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +0.0% | +0.0% | — | — |
| Stock price | +363.2% | — | — | — |
4-Factor Sector Score
41.4/100 — rank 30 of 30 in Electronic Components · 45% evidence confidence · provisional, ranked below fully-evidenced peers
Syntec Optics Holdings, Inc. scores 41.4 out of 100 against the 30 companies it is compared with in Electronic Components, ranking 30. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 11.2 + 6.2 + 8.6 + 15.4 = 41.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Syntec Optics Holdings, Inc. reported $0.0 B of revenue in the Mar 26 quarter, +0.0% year on year. Over 3 years it has compounded at 0.0% a year. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.0 B.
FY25 revenue came in at $0.0 B (+0.0% on the year), capping 3 years at 0.0% compound. The latest quarter (Mar 26) printed $0.0 B, +0.0% year on year.
Pace check: the last four quarters averaged +0.0% growth against the decade's 0.0% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +0.0% over the last 4 quarters against +0.0%/yr over the last 8 — stabilising.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Syntec Optics Holdings, Inc.'s operating margin is 0.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 0.0% to 0.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.0%, +0.0 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 0.0%–0.0%.
Why the margin moved: operating margin went +0.0 pp year on year while gross margin went +0.0 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Syntec Optics Holdings, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Syntec Optics Holdings, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.0 B of operating cash against $0.0 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.0 B against reported profit of $0.0 B, leaving free cash of $0.0 B after $0.0 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Syntec Optics Holdings, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Syntec Optics Holdings, Inc. earns a ROE of 0% in FY25. That is up from a trough of 0% in FY22. Return on invested capital clears the cost of that capital by −9.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 0.0% net margin on 1.50× asset turns.
FY25 ROE is 0%, recovered from a FY22 trough of 0% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): 0.0% net margin × 1.50× asset turns × 2.00× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: −9.2% − 0.1% = a −9.3 pp spread. The 0.1% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
Syntec Optics Holdings, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Syntec Optics Holdings, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Syntec Optics Holdings, Inc. carries total debt of $0.0 B against shareholder equity of $0.0 B as of Mar 26, a debt-to-equity of 1.00. On the annual view that ratio went from 0.00 in FY21 to 1.00 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $0.0 B against shareholder equity of $0.0 B — a debt-to-equity of 1.00. On the annual view, debt-to-equity went from 0.00 (FY21) to 1.00 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
23.4% of Syntec Optics Holdings, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 2.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 23.4% of the float is sold short, and at typical trading volumes it would take about 2.5 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Syntec Optics Holdings, Inc.: the Z-score reads 5.58. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 5.58 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 5.58.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jabil Inc.JBL | 58.5/100Mixed-positive evidence81% evidence | ASLEEP | 22.1/35 Revenue 17.8% · PAT 49.2% · OPM change 0 pp 83% evidence | 14.3/25 ROCE 9% · OPM 5.1% 76% evidence | 14.6/20 P/E 45.5× · PEG 0.82 65% evidence | 7.5/20 RS sector -10% · RS bench 15% · 1Y 51.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 14.3 + 14.6 + 7.5 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Amphenol CorporationAPH | 57.3/100Thin evidence · provisional56% evidence | TURNING | 20.3/35 Revenue — · PAT — · OPM change 2.7 pp 39% evidence | 17.4/25 ROCE 9.3% · OPM 24% 76% evidence | 9.9/20 P/E 44.2× · PEG — 15% evidence | 9.7/20 RS sector -14.7% · RS bench 11.7% · 1Y 55.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.3 + 17.4 + 9.9 + 9.7 = 57.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3CTS CorporationCTS | 55.9/100Thin evidence · provisional56% evidence | TURNING | 19.4/35 Revenue — · PAT — · OPM change 2.9 pp 39% evidence | 14.2/25 ROCE 3.9% · OPM 15.8% 76% evidence | 10.7/20 P/E 27.4× · PEG — 15% evidence | 11.6/20 RS sector -6.8% · RS bench 20% · 1Y 71.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 14.2 + 10.7 + 11.6 = 55.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Methode Electronics, Inc.MEI | 55.2/100Mixed-positive evidence64% evidence | LEADER | 19.0/35 Revenue -2.8% · PAT — · OPM change 12.9 pp 62% evidence | 5.2/25 ROCE 1% · OPM 3.7% 76% evidence | 11.2/20 P/E 21.4× · PEG — 15% evidence | 19.8/20 RS sector 20.9% · RS bench 53.4% · 1Y 133%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 5.2 + 11.2 + 19.8 = 55.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Allient Inc.ALNT | 55.0/100Thin evidence · provisional60% evidence | BREAKING OUT | 18.6/35 Revenue 8.7% · PAT 100% · OPM change 0.1 pp 53% evidence | 10.1/25 ROCE 1.8% · OPM 6.7% 57% evidence | 11.3/20 P/E 41.3× · PEG 1.47 65% evidence | 15.0/20 RS sector 4.6% · RS bench 33.1% · 1Y 125.1%11 of 12 weeks ahead 70% evidence |
| Exact sum: 18.6 + 10.1 + 11.3 + 15 = 55 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Knowles CorporationKN | 54.9/100Thin evidence · provisional56% evidence | LEADER | 20.1/35 Revenue — · PAT — · OPM change 7.4 pp 39% evidence | 9.1/25 ROCE 2.6% · OPM 10.4% 76% evidence | 9.5/20 P/E 53.9× · PEG — 15% evidence | 16.2/20 RS sector 3.1% · RS bench 31.5% · 1Y 102.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 9.1 + 9.5 + 16.2 = 54.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Celestica Inc.CLS | 54.1/100Thin evidence · provisional56% evidence | ASLEEP | 21.7/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence | 16.6/25 ROCE 14% · OPM 6.7% 76% evidence | 10.5/20 P/E 37.9× · PEG — 15% evidence | 5.3/20 RS sector -15.9% · RS bench 8.9% · 1Y 78.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 16.6 + 10.5 + 5.3 = 54.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8M-tron Industries, Inc.MPTI | 53.2/100Thin evidence · provisional60% evidence | FADING | 14.7/35 Revenue 9.8% · PAT 12.5% · OPM change 2 pp 53% evidence | 13.6/25 ROCE 4.9% · OPM 17.8% 57% evidence | 14.2/20 P/E 25.9× · PEG 0.98 65% evidence | 10.7/20 RS sector -3.4% · RS bench 23% · 1Y 102.9%11 of 12 weeks ahead 70% evidence |
| Exact sum: 14.7 + 13.6 + 14.2 + 10.7 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Littelfuse, Inc.LFUS | 52.6/100Thin evidence · provisional56% evidence | ASLEEP | 19.2/35 Revenue — · PAT — · OPM change 2.7 pp 39% evidence | 12.0/25 ROCE 3.4% · OPM 15.4% 76% evidence | 9.4/20 P/E 54.9× · PEG — 15% evidence | 12.0/20 RS sector -1% · RS bench 25.8% · 1Y 87.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 12 + 9.4 + 12 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Plexus Corp.PLXS | 51.9/100Thin evidence · provisional56% evidence | FADING | 16.6/35 Revenue — · PAT — · OPM change 0 pp 39% evidence | 11.7/25 ROCE 3.7% · OPM 5.3% 76% evidence | 10.3/20 P/E 40.6× · PEG — 15% evidence | 13.3/20 RS sector 0.9% · RS bench 27.2% · 1Y 113.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.7 + 10.3 + 13.3 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Vicor CorporationVICR | 51.4/100Thin evidence · provisional56% evidence | FADING | 16.9/35 Revenue — · PAT — · OPM change 15.1 pp 39% evidence | 13.7/25 ROCE 4.8% · OPM 14.9% 76% evidence | 8.7/20 P/E 121.7× · PEG — 15% evidence | 12.1/20 RS sector 8% · RS bench 28.5% · 1Y 383.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 13.7 + 8.7 + 12.1 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Flex Ltd.FLEX | 51.1/100Thin evidence · provisional56% evidence | FADING | 16.6/35 Revenue — · PAT — · OPM change 0.2 pp 39% evidence | 11.4/25 ROCE 3.7% · OPM 5% 76% evidence | 9.3/20 P/E 56.6× · PEG — 15% evidence | 13.8/20 RS sector 12.2% · RS bench 39.2% · 1Y 151.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.4 + 9.3 + 13.8 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Benchmark Electronics, Inc.BHE | 50.8/100Thin evidence · provisional56% evidence | FADING | 18.4/35 Revenue — · PAT — · OPM change 1.3 pp 39% evidence | 9.1/25 ROCE 2.1% · OPM 3.2% 76% evidence | 9.2/20 P/E 67.1× · PEG — 15% evidence | 14.1/20 RS sector 5.3% · RS bench 31.9% · 1Y 122.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 9.1 + 9.2 + 14.1 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14TE Connectivity plcTEL | 50.4/100Thin evidence · provisional56% evidence | TURNING | 18.0/35 Revenue — · PAT — · OPM change 2 pp 39% evidence | 15.6/25 ROCE 4.8% · OPM 20.1% 76% evidence | 11.5/20 P/E 19× · PEG — 15% evidence | 5.3/20 RS sector -33.3% · RS bench -10.8% · 1Y 7.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 15.6 + 11.5 + 5.3 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Daktronics, Inc.DAKT | 48.4/100Thin evidence · provisional58% evidence | TURNING | 22.7/35 Revenue 10.8% · PAT — · OPM change 7.8 pp 62% evidence | 10.6/25 ROCE 4.1% · OPM 6.8% 76% evidence | 11.1/20 P/E 21.4× · PEG — 15% evidence | 4.0/20 RS sector -28% · RS bench -4.7% · 1Y 26.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 22.7 + 10.6 + 11.1 + 4 = 48.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Sanmina CorporationSANM | 47.9/100Thin evidence · provisional56% evidence | FADING | 18.7/35 Revenue — · PAT — · OPM change -0.7 pp 39% evidence | 13.3/25 ROCE 5.3% · OPM 3.9% 76% evidence | 10.1/20 P/E 42.3× · PEG — 15% evidence | 5.8/20 RS sector -11.6% · RS bench 12.6% · 1Y 71.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 13.3 + 10.1 + 5.8 = 47.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17TTM Technologies, Inc.TTMI | 47.3/100Mixed-negative evidence66% evidence | FADING | 20.5/35 Revenue 25.4% · PAT 84.9% · OPM change 0.9 pp 53% evidence | 10.1/25 ROCE 2.6% · OPM 8.6% 57% evidence | 8.8/20 P/E 47.7× · PEG 1.82 65% evidence | 7.9/20 RS sector -2.3% · RS bench 18.8% · 1Y 193.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 10.1 + 8.8 + 7.9 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bel Fuse Inc.BELFA | 46.6/100Thin evidence · provisional56% evidence | ASLEEP | 15.9/35 Revenue — · PAT — · OPM change -3.1 pp 39% evidence | 13.8/25 ROCE 4% · OPM 13.3% 76% evidence | 9.1/20 P/E 74.5× · PEG — 15% evidence | 7.8/20 RS sector -4.9% · RS bench 19.6% · 1Y 109.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 13.8 + 9.1 + 7.8 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Universal Display CorporationOLED | 44.4/100Thin evidence · provisional56% evidence | BASING | 14.1/35 Revenue — · PAT — · OPM change -11.8 pp 39% evidence | 13.7/25 ROCE 3% · OPM 30.1% 76% evidence | 11.3/20 P/E 21× · PEG — 15% evidence | 5.3/20 RS sector -50% · RS bench -31.1% · 1Y -37.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 13.7 + 11.3 + 5.3 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Corning IncorporatedGLW | 44.3/100Thin evidence · provisional56% evidence | ASLEEP | 17.9/35 Revenue — · PAT — · OPM change 2.5 pp 39% evidence | 11.1/25 ROCE 2.8% · OPM 15.4% 76% evidence | 8.8/20 P/E 116.6× · PEG — 15% evidence | 6.5/20 RS sector -5.8% · RS bench 16.8% · 1Y 143.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 11.1 + 8.8 + 6.5 = 44.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Rogers CorporationROG | 44.2/100Thin evidence · provisional56% evidence | FADING | 22.2/35 Revenue — · PAT — · OPM change 5.5 pp 39% evidence | 7.0/25 ROCE 1.5% · OPM 5.3% 76% evidence | 8.9/20 P/E 93.6× · PEG — 15% evidence | 6.1/20 RS sector -12.2% · RS bench 11.8% · 1Y 88.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 7 + 8.9 + 6.1 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22LSI Industries Inc.LYTS | 36.5/100Thin evidence · provisional60% evidence | FADING | 15.1/35 Revenue 11.5% · PAT 17.4% · OPM change -2 pp 53% evidence | 8.8/25 ROCE 0.9% · OPM 2.7% 57% evidence | 6.8/20 P/E 24.8× · PEG 3.44 65% evidence | 5.8/20 RS sector -22.7% · RS bench 1.9% · 1Y 34.8%6 of 12 weeks ahead 70% evidence |
| Exact sum: 15.1 + 8.8 + 6.8 + 5.8 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Kopin CorporationKOPN | 36.5/100Thin evidence · provisional51% evidence | FADING | 15.4/35 Revenue -23.5% · PAT — · OPM change -19.6 pp 40% evidence | 5.5/25 ROCE -12.6% · OPM -56.7% 57% evidence | 8.5/20 P/E 181.5× · PEG — 15% evidence | 7.1/20 RS sector -5.4% · RS bench 20.3% · 1Y 116.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 5.5 + 8.5 + 7.1 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24OSI Systems, Inc.OSIS | 35.6/100Mixed-negative evidence66% evidence | BASING | 12.6/35 Revenue 7% · PAT 7.8% · OPM change -1 pp 53% evidence | 12.2/25 ROCE 3% · OPM 11.7% 57% evidence | 5.6/20 P/E 30.3× · PEG 4.61 65% evidence | 5.2/20 RS sector -37.2% · RS bench -16% · 1Y 4.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 12.2 + 5.6 + 5.2 = 35.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Ouster, Inc.OUST | 57.2/100Thin evidence · provisional48% evidence | LEADER | 22.1/35 Revenue 57.6% · PAT — · OPM change 33.5 pp 40% evidence | 5.7/25 ROCE -8% · OPM -39.5% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 19.4/20 RS sector 14.5% · RS bench 48.9% · 1Y 85.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 5.7 + 10 + 19.4 = 57.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Richardson Electronics, Ltd.RELL | 50.1/100Thin evidence · provisional50% evidence | LEADER | 16.4/35 Revenue — · PAT — · OPM change -1.3 pp 39% evidence | 6.6/25 ROCE 1.9% · OPM 2.7% 76% evidence | 10.4/20 P/E 38.6× · PEG — 15% evidence | 16.7/20 RS sector 18.2% · RS bench 50.7% · 1Y 122.9%12 of 12 weeks ahead 70% evidence |
| Exact sum: 16.4 + 6.6 + 10.4 + 16.7 = 50.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Ralliant CorporationRAL | 48.2/100Thin evidence · provisional50% evidence | LEADER | 18.1/35 Revenue — · PAT — · OPM change 1 pp 39% evidence | 10.0/25 ROCE 2.1% · OPM 12.7% 76% evidence | 11.4/20 P/E 20.8× · PEG — 15% evidence | 8.7/20 RS sector -8.5% · RS bench 18.8% · 1Y 48.7%12 of 12 weeks ahead 70% evidence |
| Exact sum: 18.1 + 10 + 11.4 + 8.7 = 48.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28FabrinetFN | 45.0/100Thin evidence · provisional46% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change 0.6 pp 24% evidence | 14.2/25 ROCE 5.6% · OPM 10.1% 57% evidence | 9.7/20 P/E 47× · PEG — 15% evidence | 2.8/20 RS sector -24.8% · RS bench -3.5% · 1Y 54.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 14.2 + 9.7 + 2.8 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29LightPath Technologies, Inc.LPTH | 44.7/100Thin evidence · provisional42% evidence | TURNING | 21.5/35 Revenue 87.9% · PAT — · OPM change 15.5 pp 40% evidence | 6.1/25 ROCE -4.4% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.1/20 RS sector -13.1% · RS bench 9.3% · 1Y 244.1%7 of 12 weeks ahead 70% evidence |
| Exact sum: 21.5 + 6.1 + 10 + 7.1 = 44.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30Syntec Optics Holdings, Inc.this pageOPTX | 41.4/100Thin evidence · provisional45% evidence | TURNING | 11.2/35 Revenue 0% · PAT — · OPM change -19.4 pp 40% evidence | 6.2/25 ROCE -5.6% · OPM -11.9% 57% evidence | 8.6/20 P/E 123× · PEG — 15% evidence | 15.4/20 RS sector 11.6% · RS bench 30.4% · 1Y 388.9%7 of 12 weeks ahead 70% evidence |
| Exact sum: 11.2 + 6.2 + 8.6 + 15.4 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Syntec Optics Holdings, Inc.'s stock price today?
Syntec Optics Holdings, Inc. trades at $7.9, +363.2% over the past year. The company is valued at $0.0 B. The stock sits at 56% of its 52-week range of $1–$13, +22.0% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. — as of 5 August 2026.
What were Syntec Optics Holdings, Inc.'s latest quarterly results?
Syntec Optics Holdings, Inc. reported revenue of $0.0 B and net profit of $0.0 B for the Mar 26 quarter. The operating margin was 0.0%, 0.0 pp higher than a year earlier. — as of 5 August 2026.
What is Syntec Optics Holdings, Inc.'s revenue?
Syntec Optics Holdings, Inc. reported revenue of $0.0 B in the Mar 26 quarter, +0.0% year on year. For the full FY25 fiscal year, revenue was $0.0 B (+0.0%). Over the last 3 years revenue compounded at 0.0% a year. — as of 5 August 2026.
What is Syntec Optics Holdings, Inc.'s profit?
Syntec Optics Holdings, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.
What is Syntec Optics Holdings, Inc.'s market cap?
Syntec Optics Holdings, Inc.'s market capitalisation is $0.0 B at a stock price of $7.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Syntec Optics Holdings, Inc. pay a dividend?
No — Syntec Optics Holdings, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is Syntec Optics Holdings, Inc. performing?
Syntec Optics Holdings, Inc.'s latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 5 August 2026.
Is Syntec Optics Holdings, Inc. beating the market?
On recent form, yes — Syntec Optics Holdings, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved +491% against the S&P 500's +24% — ahead of the index over the full window. — as of 5 August 2026.
Will Syntec Optics Holdings, Inc.'s stock price go up?
This page publishes no price forecast for Syntec Optics Holdings, Inc. What it measures instead: the stock price is $7.9. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Syntec Optics Holdings, Inc.?
Yes — short interest is 23.4% of Syntec Optics Holdings, Inc.'s tradable float, about 2.5 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Syntec Optics Holdings, Inc. have too much debt?
It carries real leverage — Syntec Optics Holdings, Inc.'s debt-to-equity is 1.29. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Syntec Optics Holdings, Inc.'s capex?
Syntec Optics Holdings, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is Syntec Optics Holdings, Inc.'s cash flow?
Syntec Optics Holdings, Inc. generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
How financially safe is Syntec Optics Holdings, Inc.?
On the balance sheet, the Z-score reads 5.58 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Syntec Optics Holdings, Inc. in its business cycle?
Syntec Optics Holdings, Inc.'s FY25 operating margin was 0.0%, against a 4-year band of 0.0%–0.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Syntec Optics Holdings, Inc. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Syntec Optics Holdings, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Syntec Optics Holdings, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.